Evidence map›Paper›PMID 42332059›Full record

ArticleJournal of human genetics2026

A trio-based long-read sequencing workflow identifies a pathogenic transposable element insertion in a previously undiagnosed patient.

Hiroyuki Mishima, Yoriko Watanabe, Uladzislau Korzun, Koh-Ichiro Yoshiura

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Hiroyuki MishimaDepartment of Human Genetics, Unit of Radiation Effects on Humans, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan. hmishima@nagasaki-u.ac.jp.ORCID http://orcid.org/0000-0001-5050-2509
Yoriko WatanabeDepartment of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, Japan.ORCID http://orcid.org/0000-0003-4685-8021
Uladzislau KorzunDepartment of Human Genetics, Unit of Radiation Effects on Humans, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.ORCID http://orcid.org/0000-0002-8596-7565
Koh-Ichiro YoshiuraDepartment of Human Genetics, Unit of Radiation Effects on Humans, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.ORCID http://orcid.org/0000-0003-3209-5780

Funding

Japan Agency for Medical Research and Development (AMED) JP25ek0109672Japan Agency for Medical Research and Development (AMED) JP25ek0109760MEXT | Japan Society for the Promotion of Science (JSPS) JP24K11001
6 · The paper itself

Abstract

Long-read sequencing (LRS) is a powerful tool for detecting structural variants (SVs), which are major causes of genetic diseases. However, the application of trio-based analysis to LRS data remains challenging due to the complexity of merging and comparing SVs across individuals. Here, we established a workflow to prioritize pathogenic SVs using trio-based LRS whole-genome sequencing. The workflow integrates high-accuracy basecalling, trio-based phasing, and multiple SV callers (CuteSV and Sniffles2). We employed the PanPop Realign and Thin (PART) process to merge SVs and utilized the JSV1 Japanese population-specific SV frequency dataset to filter common variants. We evaluated this workflow using 12 family trios from the Initiatives for Rare and Undiagnosed Diseases (IRUD) project. The workflow successfully prioritized candidate SVs by narrowing down tens of thousands of loci to less than ~20 with X-linked homozygous and de novo models for manual inspection. Notably, we identified a pathogenic AluY element insertion in the GPC3 gene in a patient with Simpson-Golabi-Behmel syndrome. This variant had been missed by previous short-read whole-exome sequencing but was clearly prioritized by our LRS workflow. Our workflow effectively prioritizes pathogenic SVs from LRS data, demonstrating the clinical utility of LRS for diagnosing rare diseases involving complex SVs without prior knowledge of candidate genes or loci.

Indexed as

DNA Transposable ElementsGenomic Structural VariationMutagenesis, InsertionalHigh-Throughput Nucleotide SequencingHumansSequence Analysis, DNAWhole Genome SequencingWorkflowDNA Transposable Elements

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.